Ibumetin 50 mg/g gels 라트비아 - 라트비아어 - Zāļu valsts aģentūra

ibumetin 50 mg/g gels

takeda pharma as, estonia - ibuprofēns - gels - 50 mg/g

Takhzyro 유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

takhzyro

takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedēma, iedzimta - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.

Alunbrig 유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

alunbrig

takeda pharma a/s - brigatinib - karcinoma, nesīkšūnu plaušas - antineoplastiski līdzekļi - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.

Qdenga 유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

qdenga

takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - denges - vakcīnas - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.

Matrifen 100 mikrogrami/stundā transdermāls plāksteris 라트비아 - 라트비아어 - Zāļu valsts aģentūra

matrifen 100 mikrogrami/stundā transdermāls plāksteris

takeda pharma as, estonia - fentanils - transdermālais plāksteris - 100 µg/stundā

Matrifen 50 mikrogrami/stundā transdermāls plāksteris 라트비아 - 라트비아어 - Zāļu valsts aģentūra

matrifen 50 mikrogrami/stundā transdermāls plāksteris

takeda pharma as, estonia - fentanils - transdermālais plāksteris - 50 µg/stundā

Matrifen 25 mikrogrami/stundā transdermāls plāksteris 라트비아 - 라트비아어 - Zāļu valsts aģentūra

matrifen 25 mikrogrami/stundā transdermāls plāksteris

takeda pharma as, estonia - fentanils - transdermālais plāksteris - 25 µg/stundā

Matrifen 12 mikrogrami/stundā transdermāls plāksteris 라트비아 - 라트비아어 - Zāļu valsts aģentūra

matrifen 12 mikrogrami/stundā transdermāls plāksteris

takeda pharma as, estonia - fentanils - transdermālais plāksteris - 12 µg/stundā

Matrifen 75 mikrogrami/stundā transdermāls plāksteris 라트비아 - 라트비아어 - Zāļu valsts aģentūra

matrifen 75 mikrogrami/stundā transdermāls plāksteris

takeda pharma as, estonia - fentanils - transdermālais plāksteris - 75 µg/stundā